In prostate cancer, loss of p62 in the stromal fibroblasts impairs mTORC1 activation, which results in a reduced metabolic detoxification capacity and the secretion of the prosurvival inflammatory cytokine IL‐6, which sustains the growth and invasiveness of the neighboring prostate cancer cells 61. The gene discussed is IL6; the disease is prostate carcinoma.